Target (CBDY) Non Operating Income (2017 - 2026)
Target (CBDY) reported Non Operating Income of -$240469.0 for Q1 2026, up 8.14% year-over-year from -$222361.5 in Q1 2025, and up 18.63% quarter-over-quarter from -$295533.0 in Q4 2025.
Target (CBDY) Non Operating Income (2017 - 2026) Analysis & Trends
Target (CBDY) has 10 years of Non Operating Income data on file, last reported at -$240469.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$240469.0, up 8.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 22.21% YoY), and the FY2025 annual result was -$1.1 million, down 19.01% from the prior year.
- Non Operating Income improved to -$240469.0 in Q1 2026 per CBDY's latest filing, from -$295533.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $1.1 million in Q2 2023 and troughed at -$3.6 million in Q4 2022.
- A 5-year average of -$323975.2 and a median of -$261626.0 in 2023 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 101.19% in 2023 and fell as far as 3829.72% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$3.6 million in 2022, then soared by 92.72% to -$261626.0 in 2023, then surged by 51.75% to -$126229.0 in 2024, then sank by 134.12% to -$295533.0 in 2025, then gained by 18.63% to -$240469.0 in 2026.
- Business Quant data shows CBDY's Non Operating Income at -$240469.0 in Q1 2026, -$295533.0 in Q4 2025, and -$223740.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Target | - | - | 191,787.00 | -240,469.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -240,469.00 |
| Dec 31, 2025 | -295,533.00 |
| Sep 30, 2025 | -223,740.00 |
| Jun 30, 2025 | -356,897.00 |
| Mar 31, 2025 | -261,787.00 |
| Dec 31, 2024 | -126,229.00 |
| Sep 30, 2024 | -291,169.00 |
| Jun 30, 2024 | -234,492.00 |
| Mar 31, 2024 | -304,322.00 |
| Dec 31, 2023 | -261,626.00 |
| Sep 30, 2023 | -300,309.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | -404,997.00 |
| Dec 31, 2022 | -3.60 Mn |
| Sep 30, 2022 | -7,642.00 |
| Jun 30, 2022 | 534,090.00 |
| Mar 31, 2022 | -211,506.00 |
| Dec 31, 2021 | 147,443.00 |
| Sep 30, 2021 | 2.62 Mn |
| Jun 30, 2021 | 1.20 Mn |